查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1467773

2024-2032 年按組件、治療領域、最終用戶和地區分類的真實世界證據解決方案市場報告

Real-World Evidence Solutions Market Report by Component, Therapeutic Area, End User, and Region 2024-2032
出版日期: | 出版商: IMARC | 英文 138 Pages | 商品交期: 2-3個工作天內

價格

2023 年，IMARC Group現實世界證據解決方案市場規模達到 18 億美元。

真實世界證據（RWE）是指透過真實世界資料（RWD）了解醫療產品的使用以及潛在益處或風險的臨床證據。它可以透過不同的研究設計或分析來產生，包括隨機試驗、大型簡單試驗、實用試驗和觀察性研究。它提供了對患者群體真實治療模式的深入了解，包括劑量、依從性、依從性、標籤外使用以及療效和安全性之間的平衡。由於它還可以幫助研究人員發現可能的患者並制定正確的臨床試驗納入標準，從而幫助他們設計更好的預試驗研究，因此全球對 RWE 解決方案的需求不斷增加。

真實世界證據解決方案市場趨勢：

對 RWE 解決方案的需求不斷成長，以獲取有關新產品安全性和功效的準確、清晰的資訊，這是推動市場發展的關鍵因素之一。此外，對這些解決方案的需求不斷增加，以檢測複雜和共病患者使用時的不同反應、產品亞群效應和產品價值。這與蓬勃發展的醫療保健行業一起推動了市場的成長。此外，RWE 擴大利用先進分析和技術解決方案進行臨床開發、商業化、加速創新和加速改善醫療保健結果，這對市場產生了積極影響。除此之外，多個國家的政府也採取了各種措施來促進 RWE 解決方案的使用，這些解決方案提供了藥物和疫苗的功效。再加上從數量型護理轉向基於價值的護理，為行業投資者提供了利潤豐厚的成長機會。除此之外，數位化和以患者為中心的虛擬護理的日益普及正在刺激對 RWE 解決方案的需求。此外，全球癌症、肥胖和糖尿病等慢性疾病的盛行率也在增加。與此一致的是，藥物開發的不斷拖延以及隨後開發成本的增加正在支持市場的成長。

本報告回答的關鍵問題

  • 2023 年全球現實世界證據解決方案市場規模有多大？
  • 2024-2032 年全球現實世界證據解決方案市場的預期成長率為何？
  • 推動全球現實世界證據解決方案市場的關鍵因素是什麼？
  • COVID-19 對全球現實世界證據解決方案市場有何影響？
  • 基於組件的全球現實世界證據解決方案市場的細分是什麼？
  • 基於治療領域的全球現實世界證據解決方案市場的細分是什麼？
  • 基於最終用戶的全球現實世界證據解決方案市場的細分是什麼？
  • 全球現實世界證據解決方案市場的關鍵區域有哪些？
  • 誰是全球現實證據解決方案市場的主要參與者/公司？

目錄

第1章：前言

第 2 章：範圍與方法

  • 研究目的
  • 利害關係人
  • 資料來源
    • 主要資源
    • 二手資料
  • 市場預測
    • 自下而上的方法
    • 自上而下的方法
  • 預測方法

第 3 章：執行摘要

第 4 章：簡介

  • 概述
  • 主要行業趨勢

第 5 章：全球真實世界證據解決方案市場

  • 市場概況
  • 市場業績
  • COVID-19 的影響
  • 市場預測

第 6 章：市場區隔：按組成部分

  • 臨床設定數據
    • 市場走向
    • 市場預測
  • 索賠數據
    • 市場走向
    • 市場預測
  • 患者驅動的數據
    • 市場走向
    • 市場預測
  • 藥房數據
    • 市場走向
    • 市場預測
  • 其他
    • 市場走向
    • 市場預測

第 7 章：市場區隔：依治療領域

  • 腫瘤學
    • 市場走向
    • 市場預測
  • 免疫學
    • 市場走向
    • 市場預測
  • 神經病學
    • 市場走向
    • 市場預測
  • 心血管疾病
    • 市場走向
    • 市場預測
  • 其他
    • 市場走向
    • 市場預測

第 8 章：市場區隔：依最終用戶

  • 製藥及醫療器材公司
    • 市場走向
    • 市場預測
  • 醫療保健支付者
    • 市場走向
    • 市場預測
  • 醫療保健機構
    • 市場走向
    • 市場預測
  • 其他
    • 市場走向
    • 市場預測

第 9 章：市場區隔：按地區

  • 北美洲
    • 美國
      • 市場走向
      • 市場預測
    • 加拿大
      • 市場走向
      • 市場預測
  • 亞太
    • 中國
      • 市場走向
      • 市場預測
    • 日本
      • 市場走向
      • 市場預測
    • 印度
      • 市場走向
      • 市場預測
    • 韓國
      • 市場走向
      • 市場預測
    • 澳洲
      • 市場走向
      • 市場預測
    • 印尼
      • 市場走向
      • 市場預測
    • 其他
      • 市場走向
      • 市場預測
  • 歐洲
    • 德國
      • 市場走向
      • 市場預測
    • 法國
      • 市場走向
      • 市場預測
    • 英國
      • 市場走向
      • 市場預測
    • 義大利
      • 市場走向
      • 市場預測
    • 西班牙
      • 市場走向
      • 市場預測
    • 俄羅斯
      • 市場走向
      • 市場預測
    • 其他
      • 市場走向
      • 市場預測
  • 拉丁美洲
    • 巴西
      • 市場走向
      • 市場預測
    • 墨西哥
      • 市場走向
      • 市場預測
    • 其他
      • 市場走向
      • 市場預測
  • 中東和非洲
    • 市場走向
    • 市場細分：按國家/地區
    • 市場預測

第 10 章：SWOT 分析

  • 概述
  • 優勢
  • 弱點
  • 機會
  • 威脅

第 11 章：價值鏈分析

第 12 章：波特五力分析

  • 概述
  • 買家的議價能力
  • 供應商的議價能力
  • 競爭程度
  • 新進入者的威脅
  • 替代品的威脅

第 13 章：價格分析

第14章：競爭格局

  • 市場結構
  • 關鍵參與者
  • 關鍵參與者簡介
    • Aetion Inc.
    • Clinigen Limited
    • Flatiron Health Inc. (Roche Holding AG)
    • ICON plc
    • International Business Machines Corporation
    • IQVIA
    • Optum Inc. (UnitedHealth Group Incorporated)
    • Oracle Corporation
    • Parexel International Corporation
    • PPD Inc. (Thermo Fisher Scientific Inc.)
    • Sas Institute Inc.
    • Syneos Health
Product Code: SR112024A6149

The global real-world evidence solutions market size reached US$ 1.8 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 3.4 Billion by 2032, exhibiting a growth rate (CAGR) of 7.6% during 2024-2032.

Real-world evidence (RWE) refers to clinical evidence about the use and potential benefits or risks of medical products via real-world data (RWD). It can be produced via different study designs or analyses, including randomized trials, big simple trials, pragmatic trials, and observational studies. It provides insight into real-world treatment patterns in patient groups, including dosing, compliance, adherence, off-label use, and the balance between efficacy and safety. As it can also assist researchers in discovering possible patients and developing correct inclusion criteria for clinical trials, which can help them design better pre-trial studies, there is a rise in the demand for RWE solutions around the world.

Real-World Evidence Solutions Market Trends:

The growing demand for RWE solutions to get precise and clear information about the safety and efficacy of new products represents one of the key factors driving the market. Moreover, there is a rise in the demand for these solutions to detect varied reactions, product subpopulation effects, and product value when utilized by complex and comorbid patients. This, along with the burgeoning healthcare industry, is propelling the growth of the market. Additionally, the growing utilization of advanced analytics and technological solutions in RWE for clinical development, commercialization, speed innovation, and accelerating improvements in healthcare outcomes is positively influencing the market. Besides this, there are various initiatives undertaken by governments of several countries to promote the use of RWE solutions, which provide the efficacy of drugs and vaccines. This, coupled with a shift from volume to value-based care, is offering lucrative growth opportunities to industry investors. Apart from this, the growing adoption of digitalization and patient-centered virtual care is catalyzing the demand for RWE solutions. Furthermore, there is an increase in the prevalence of chronic diseases, such as cancer, obesity, and diabetes, across the globe. In line with this, the rising delays in drug development and the subsequent increase in development costs are bolstering the growth of the market.

Key Market Segmentation:

IMARC Group provides an analysis of the key trends in each sub-segment of the global real-world evidence solutions market report, along with forecasts at the global, regional and country levels from 2024-2032. Our report has categorized the market based on component, therapeutic area and end user.

Breakup by Component:

Clinical Settings Data

Claims Data

Patient-Powered Data

Pharmacy Data

Others

Breakup by Therapeutic Area:

Oncology

Immunology

Neurology

Cardiovascular Disease

Others

Breakup by End User:

Pharmaceutical and Medical Device Companies

Healthcare Payers

Healthcare Providers

Others

Breakup by Region:

North America

United States

Canada

Asia-Pacific

China

Japan

India

South Korea

Australia

Indonesia

Others

Europe

Germany

France

United Kingdom

Italy

Spain

Russia

Others

Latin America

Brazil

Mexico

Others

Middle East and Africa

Competitive Landscape:

The competitive landscape of the industry has also been examined along with the profiles of the key players being Aetion Inc., Clinigen Limited, Flatiron Health Inc. (Roche Holding AG), ICON plc, International Business Machines Corporation, IQVIA, Optum Inc. (UnitedHealth Group Incorporated), Oracle Corporation, Parexel International Corporation, PPD Inc. (Thermo Fisher Scientific Inc.), Sas Institute Inc. and Syneos Health.

Key Questions Answered in This Report

  • 1. What was the size of the global real-world evidence solutions market in 2023?
  • 2. What is the expected growth rate of the global real-world evidence solutions market during 2024-2032?
  • 3. What are the key factors driving the global real-world evidence solutions market?
  • 4. What has been the impact of COVID-19 on the global real-world evidence solutions market?
  • 5. What is the breakup of the global real-world evidence solutions market based on the component?
  • 6. What is the breakup of the global real-world evidence solutions market based on the therapeutic area?
  • 7. What is the breakup of the global real-world evidence solutions market based on the end user?
  • 8. What are the key regions in the global real-world evidence solutions market?
  • 9. Who are the key players/companies in the global real-world evidence solutions market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Real-World Evidence Solutions Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Component

  • 6.1 Clinical Settings Data
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2 Claims Data
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast
  • 6.3 Patient-Powered Data
    • 6.3.1 Market Trends
    • 6.3.2 Market Forecast
  • 6.4 Pharmacy Data
    • 6.4.1 Market Trends
    • 6.4.2 Market Forecast
  • 6.5 Others
    • 6.5.1 Market Trends
    • 6.5.2 Market Forecast

7 Market Breakup by Therapeutic Area

  • 7.1 Oncology
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Immunology
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast
  • 7.3 Neurology
    • 7.3.1 Market Trends
    • 7.3.2 Market Forecast
  • 7.4 Cardiovascular Disease
    • 7.4.1 Market Trends
    • 7.4.2 Market Forecast
  • 7.5 Others
    • 7.5.1 Market Trends
    • 7.5.2 Market Forecast

8 Market Breakup by End User

  • 8.1 Pharmaceutical and Medical Device Companies
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Healthcare Payers
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast
  • 8.3 Healthcare Providers
    • 8.3.1 Market Trends
    • 8.3.2 Market Forecast
  • 8.4 Others
    • 8.4.1 Market Trends
    • 8.4.2 Market Forecast

9 Market Breakup by Region

  • 9.1 North America
    • 9.1.1 United States
      • 9.1.1.1 Market Trends
      • 9.1.1.2 Market Forecast
    • 9.1.2 Canada
      • 9.1.2.1 Market Trends
      • 9.1.2.2 Market Forecast
  • 9.2 Asia-Pacific
    • 9.2.1 China
      • 9.2.1.1 Market Trends
      • 9.2.1.2 Market Forecast
    • 9.2.2 Japan
      • 9.2.2.1 Market Trends
      • 9.2.2.2 Market Forecast
    • 9.2.3 India
      • 9.2.3.1 Market Trends
      • 9.2.3.2 Market Forecast
    • 9.2.4 South Korea
      • 9.2.4.1 Market Trends
      • 9.2.4.2 Market Forecast
    • 9.2.5 Australia
      • 9.2.5.1 Market Trends
      • 9.2.5.2 Market Forecast
    • 9.2.6 Indonesia
      • 9.2.6.1 Market Trends
      • 9.2.6.2 Market Forecast
    • 9.2.7 Others
      • 9.2.7.1 Market Trends
      • 9.2.7.2 Market Forecast
  • 9.3 Europe
    • 9.3.1 Germany
      • 9.3.1.1 Market Trends
      • 9.3.1.2 Market Forecast
    • 9.3.2 France
      • 9.3.2.1 Market Trends
      • 9.3.2.2 Market Forecast
    • 9.3.3 United Kingdom
      • 9.3.3.1 Market Trends
      • 9.3.3.2 Market Forecast
    • 9.3.4 Italy
      • 9.3.4.1 Market Trends
      • 9.3.4.2 Market Forecast
    • 9.3.5 Spain
      • 9.3.5.1 Market Trends
      • 9.3.5.2 Market Forecast
    • 9.3.6 Russia
      • 9.3.6.1 Market Trends
      • 9.3.6.2 Market Forecast
    • 9.3.7 Others
      • 9.3.7.1 Market Trends
      • 9.3.7.2 Market Forecast
  • 9.4 Latin America
    • 9.4.1 Brazil
      • 9.4.1.1 Market Trends
      • 9.4.1.2 Market Forecast
    • 9.4.2 Mexico
      • 9.4.2.1 Market Trends
      • 9.4.2.2 Market Forecast
    • 9.4.3 Others
      • 9.4.3.1 Market Trends
      • 9.4.3.2 Market Forecast
  • 9.5 Middle East and Africa
    • 9.5.1 Market Trends
    • 9.5.2 Market Breakup by Country
    • 9.5.3 Market Forecast

10 SWOT Analysis

  • 10.1 Overview
  • 10.2 Strengths
  • 10.3 Weaknesses
  • 10.4 Opportunities
  • 10.5 Threats

11 Value Chain Analysis

12 Porters Five Forces Analysis

  • 12.1 Overview
  • 12.2 Bargaining Power of Buyers
  • 12.3 Bargaining Power of Suppliers
  • 12.4 Degree of Competition
  • 12.5 Threat of New Entrants
  • 12.6 Threat of Substitutes

13 Price Analysis

14 Competitive Landscape

  • 14.1 Market Structure
  • 14.2 Key Players
  • 14.3 Profiles of Key Players
    • 14.3.1 Aetion Inc.
      • 14.3.1.1 Company Overview
      • 14.3.1.2 Product Portfolio
    • 14.3.2 Clinigen Limited
      • 14.3.2.1 Company Overview
      • 14.3.2.2 Product Portfolio
      • 14.3.2.3 Financials
    • 14.3.3 Flatiron Health Inc. (Roche Holding AG)
      • 14.3.3.1 Company Overview
      • 14.3.3.2 Product Portfolio
    • 14.3.4 ICON plc
      • 14.3.4.1 Company Overview
      • 14.3.4.2 Product Portfolio
      • 14.3.4.3 Financials
      • 14.3.4.4 SWOT Analysis
    • 14.3.5 International Business Machines Corporation
      • 14.3.5.1 Company Overview
      • 14.3.5.2 Product Portfolio
      • 14.3.5.3 Financials
    • 14.3.6 IQVIA
      • 14.3.6.1 Company Overview
      • 14.3.6.2 Product Portfolio
      • 14.3.6.3 Financials
      • 14.3.6.4 SWOT Analysis
    • 14.3.7 Optum Inc. (UnitedHealth Group Incorporated)
      • 14.3.7.1 Company Overview
      • 14.3.7.2 Product Portfolio
    • 14.3.8 Oracle Corporation
      • 14.3.8.1 Company Overview
      • 14.3.8.2 Product Portfolio
      • 14.3.8.3 Financials
      • 14.3.8.4 SWOT Analysis
    • 14.3.9 Parexel International Corporation
      • 14.3.9.1 Company Overview
      • 14.3.9.2 Product Portfolio
      • 14.3.9.3 Financials
    • 14.3.10 PPD Inc. (Thermo Fisher Scientific Inc.)
      • 14.3.10.1 Company Overview
      • 14.3.10.2 Product Portfolio
    • 14.3.11 Sas Institute Inc.
      • 14.3.11.1 Company Overview
      • 14.3.11.2 Product Portfolio
      • 14.3.11.3 SWOT Analysis
    • 14.3.12 Syneos Health
      • 14.3.12.1 Company Overview
      • 14.3.12.2 Product Portfolio
      • 14.3.12.3 Financials
      • 14.3.12.4 SWOT Analysis

List of Figures

  • Figure 1: Global: Real-World Evidence Solutions Market: Major Drivers and Challenges
  • Figure 2: Global: Real-World Evidence Solutions Market: Sales Value (in Billion US$), 2018-2023
  • Figure 3: Global: Real-World Evidence Solutions Market Forecast: Sales Value (in Billion US$), 2024-2032
  • Figure 4: Global: Real-World Evidence Solutions Market: Breakup by Component (in %), 2023
  • Figure 5: Global: Real-World Evidence Solutions Market: Breakup by Therapeutic Area (in %), 2023
  • Figure 6: Global: Real-World Evidence Solutions Market: Breakup by End User (in %), 2023
  • Figure 7: Global: Real-World Evidence Solutions Market: Breakup by Region (in %), 2023
  • Figure 8: Global: Real-World Evidence Solutions (Clinical Settings Data) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 9: Global: Real-World Evidence Solutions (Clinical Settings Data) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 10: Global: Real-World Evidence Solutions (Claims Data) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 11: Global: Real-World Evidence Solutions (Claims Data) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 12: Global: Real-World Evidence Solutions (Patient-Powered Data) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 13: Global: Real-World Evidence Solutions (Patient-Powered Data) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 14: Global: Real-World Evidence Solutions (Pharmacy Data) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 15: Global: Real-World Evidence Solutions (Pharmacy Data) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 16: Global: Real-World Evidence Solutions (Other Components) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 17: Global: Real-World Evidence Solutions (Other Components) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 18: Global: Real-World Evidence Solutions (Oncology) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 19: Global: Real-World Evidence Solutions (Oncology) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 20: Global: Real-World Evidence Solutions (Immunology) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 21: Global: Real-World Evidence Solutions (Immunology) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 22: Global: Real-World Evidence Solutions (Neurology) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 23: Global: Real-World Evidence Solutions (Neurology) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 24: Global: Real-World Evidence Solutions (Cardiovascular Disease) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 25: Global: Real-World Evidence Solutions (Cardiovascular Disease) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 26: Global: Real-World Evidence Solutions (Other Therapeutic Areas) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 27: Global: Real-World Evidence Solutions (Other Therapeutic Areas) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 28: Global: Real-World Evidence Solutions (Pharmaceutical and Medical Device Companies) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 29: Global: Real-World Evidence Solutions (Pharmaceutical and Medical Device Companies) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 30: Global: Real-World Evidence Solutions (Healthcare Payers) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 31: Global: Real-World Evidence Solutions (Healthcare Payers) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 32: Global: Real-World Evidence Solutions (Healthcare Providers) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 33: Global: Real-World Evidence Solutions (Healthcare Providers) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 34: Global: Real-World Evidence Solutions (Other End Users) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 35: Global: Real-World Evidence Solutions (Other End Users) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 36: North America: Real-World Evidence Solutions Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 37: North America: Real-World Evidence Solutions Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 38: United States: Real-World Evidence Solutions Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 39: United States: Real-World Evidence Solutions Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 40: Canada: Real-World Evidence Solutions Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 41: Canada: Real-World Evidence Solutions Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 42: Asia-Pacific: Real-World Evidence Solutions Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 43: Asia-Pacific: Real-World Evidence Solutions Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 44: China: Real-World Evidence Solutions Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 45: China: Real-World Evidence Solutions Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 46: Japan: Real-World Evidence Solutions Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 47: Japan: Real-World Evidence Solutions Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 48: India: Real-World Evidence Solutions Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 49: India: Real-World Evidence Solutions Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 50: South Korea: Real-World Evidence Solutions Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 51: South Korea: Real-World Evidence Solutions Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 52: Australia: Real-World Evidence Solutions Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 53: Australia: Real-World Evidence Solutions Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 54: Indonesia: Real-World Evidence Solutions Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 55: Indonesia: Real-World Evidence Solutions Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 56: Others: Real-World Evidence Solutions Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 57: Others: Real-World Evidence Solutions Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 58: Europe: Real-World Evidence Solutions Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 59: Europe: Real-World Evidence Solutions Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 60: Germany: Real-World Evidence Solutions Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 61: Germany: Real-World Evidence Solutions Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 62: France: Real-World Evidence Solutions Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 63: France: Real-World Evidence Solutions Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 64: United Kingdom: Real-World Evidence Solutions Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 65: United Kingdom: Real-World Evidence Solutions Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 66: Italy: Real-World Evidence Solutions Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 67: Italy: Real-World Evidence Solutions Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 68: Spain: Real-World Evidence Solutions Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 69: Spain: Real-World Evidence Solutions Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 70: Russia: Real-World Evidence Solutions Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 71: Russia: Real-World Evidence Solutions Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 72: Others: Real-World Evidence Solutions Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 73: Others: Real-World Evidence Solutions Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 74: Latin America: Real-World Evidence Solutions Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 75: Latin America: Real-World Evidence Solutions Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 76: Brazil: Real-World Evidence Solutions Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 77: Brazil: Real-World Evidence Solutions Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 78: Mexico: Real-World Evidence Solutions Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 79: Mexico: Real-World Evidence Solutions Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 80: Others: Real-World Evidence Solutions Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 81: Others: Real-World Evidence Solutions Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 82: Middle East and Africa: Real-World Evidence Solutions Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 83: Middle East and Africa: Real-World Evidence Solutions Market: Breakup by Country (in %), 2023
  • Figure 84: Middle East and Africa: Real-World Evidence Solutions Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 85: Global: Real-World Evidence Solutions Industry: SWOT Analysis
  • Figure 86: Global: Real-World Evidence Solutions Industry: Value Chain Analysis
  • Figure 87: Global: Real-World Evidence Solutions Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Real-World Evidence Solutions Market: Key Industry Highlights, 2023 and 2032
  • Table 2: Global: Real-World Evidence Solutions Market Forecast: Breakup by Component (in Million US$), 2024-2032
  • Table 3: Global: Real-World Evidence Solutions Market Forecast: Breakup by Therapeutic Area (in Million US$), 2024-2032
  • Table 4: Global: Real-World Evidence Solutions Market Forecast: Breakup by End User (in Million US$), 2024-2032
  • Table 5: Global: Real-World Evidence Solutions Market Forecast: Breakup by Region (in Million US$), 2024-2032
  • Table 6: Global: Real-World Evidence Solutions Market: Competitive Structure
  • Table 7: Global: Real-World Evidence Solutions Market: Key Players